Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America


  • Ross Levine, MD, Memorial Sloan-Kettering Cancer Center

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.
View full description


Book information

  • Published: October 2012
  • Imprint: SAUNDERS
  • ISBN: 978-1-4557-4941-6